Medicare Enrolled

Dr. Mohammadbagher Ziari, MD

Hematology & Oncology · Corona, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1280 CORONA POINTE CT STE 112, Corona, CA 92879
9518982828
In practice since 2007 (18 years)
NPI: 1962601047 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ziari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ziari? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ziari

Dr. Mohammadbagher Ziari is a hematology & oncology specialist in Corona, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ziari performed 630 Medicare services across 363 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ziari received a total of $2,394,551 from 62 pharmaceutical and/or device companies across 2225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ziari is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 630 Medicare services $2,394,551 industry payments

Medicare Practice Summary

Medicare Utilization ↗
630
Medicare services
Bottom 41% in CA for hematology & oncology
363
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
502 $81 $316
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
78 $131 $594
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
50 $44 $167
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,394,551
Total received (2018-2024)
Avg $342,079/year across 7 years
Top 0% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
2,225
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,339,182 (97.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$50,957 (2.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,412 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$282,214
2023
$428,532
2022
$495,492
2021
$482,264
2020
$220,023
2019
$264,541
2018
$221,485

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$99,719
AstraZeneca Pharmaceuticals LP
$65,268
EMD Serono, Inc.
$57,260
Lilly USA, LLC
$36,364
E.R. Squibb & Sons, L.L.C.
$7,761
Daiichi Sankyo Inc.
$5,618
Amgen Inc.
$3,247
SERVIER PHARMACEUTICALS LLC
$2,380
Alnylam Pharmaceuticals Inc.
$2,300
ABBVIE INC.
$1,675
Celgene Corporation
$140
Incyte Corporation
$125
SOBI, INC
$121
Rigel Pharmaceuticals, Inc.
$120
Myriad Genetic Laboratories, Inc.
$117
Top 3 companies account for 78.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$840,233
Regeneron Healthcare Solutions, Inc.
$278,638
Karyopharm Therapeutics Inc.
$275,557
E.R. Squibb & Sons, L.L.C.
$218,985
Lilly USA, LLC
$116,146
Amgen Inc.
$115,426
Daiichi Sankyo Inc.
$95,248
Celgene Corporation
$92,831
EMD Serono, Inc.
$91,735
GENZYME CORPORATION
$78,729
Merck Sharp & Dohme Corporation
$45,512
Agios Pharmaceuticals, Inc.
$22,172
Servier Pharmaceuticals LLC
$16,242
AbbVie Inc.
$15,716
SERVIER PHARMACEUTICALS LLC
$14,666
Myriad Genetic Laboratories, Inc.
$13,491
PFIZER INC.
$10,047
ABBVIE INC.
$7,864
Taiho Oncology, Inc.
$6,362
Janssen Scientific Affairs, LLC
$5,015
Puma Biotechnology, Inc.
$4,295
Novartis Pharmaceuticals Corporation
$3,769
TESARO, Inc.
$3,410
Incyte Corporation
$2,957
ARRAY BIOPHARMA INC
$2,540
Takeda Pharmaceuticals U.S.A., Inc.
$2,528
SOBI, INC
$2,431
Alnylam Pharmaceuticals Inc.
$2,300
Dova Pharmaceuticals
$2,070
Eisai Inc.
$1,639
Secura Bio, Inc.
$1,515
TG THERAPEUTICS, INC.
$945
CTI BioPharma Corp.
$675
Epizyme, Inc.,
$525
Alexion Pharmaceuticals, Inc.
$274
JAZZ PHARMACEUTICALS INC.
$244
Rigel Pharmaceuticals, Inc.
$244
Novocure GmbH
$200
Seagen Inc.
$193
Janssen Biotech, Inc.
$179
Athenex Pharmaceutical Division, LLC
$175
COMSORT, Inc
$150
GlaxoSmithKline, LLC.
$124
Medtronic, Inc.
$101
Pharmacyclics LLC, An AbbVie Company
$42
Merck Sharp & Dohme LLC
$41
Mylan Institutional Inc.
$41
PUMA BIOTECHNOLOGY, INC.
$40
Lexicon Pharmaceuticals, Inc.
$32
Pharmacosmos Therapeutics Inc.
$28
Foundation Medicine, Inc.
$25
Array BioPharma Inc.
$24
Genentech USA, Inc.
$24
Blueprint Medicines Corporation
$23
Bayer HealthCare Pharmaceuticals Inc.
$23
Jazz Pharmaceuticals Inc.
$22
EISAI INC.
$19
TOLMAR Pharmaceuticals, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Janssen Pharmaceuticals, Inc
$15
SANOFI-AVENTIS U.S. LLC
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 58.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · BALVERSA · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · Balversa · Bavencio · Braftovi · CABLIVI · CALQUENCE · CREON · Doptelet · ELIGARD · ELITEK · EMPLICITI · ENHERTU · Enhertu · Erleada · FARYDAK · FOUNDATIONONE · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYCHOICE CDX · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · ONCASPAR · ONUREG · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · PADCEV · PIQRAY · PROMACTA · Pomalyst · REBLOZYL · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · TAGRISSO · TIBSOVO · Tibsovo · UKONIQ · ULTOMIRIS · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vonjo · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · ZEJULA · ZEPZELCA · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for hematology & oncology in CA.

Looking for a hematology & oncology specialist in Corona?
Compare hematology & oncology specialists in the Corona area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
128
Per 100K population
5.2
County median income
$89,672
Nearest hospital
KAISER FOUNDATION HOSPITAL, RIVERSIDE
3.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ziari is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ziari experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ziari performed 502 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ziari receive payments from pharmaceutical companies?
Yes. Dr. Ziari received a total of $2,394,551 from 62 companies across 2,225 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ziari's costs compare to other hematology & oncology specialists in Corona?
Dr. Ziari's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ziari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →